Publication list
2024
Jakab, Á.,
Kovács, F.,
Balla, N.,
Nagy-Köteles, C.,
Ragyák, Á.,
Nagy, F.,
Borman, A.,
Majoros, L.,
Kovács, R.:
Comparative transcriptional analysis of Candida auris biofilms following farnesol and tyrosol treatment.
Microbiol. Spectr. 12 (4), 1-12, 2024.
Journal metrics:
Q2 Cell Biology (2023)
Q1 Ecology (2023)
Q2 Genetics (2023)
Q1 Immunology and Microbiology (miscellaneous) (2023)
Q1 Infectious Diseases (2023)
Q2 Microbiology (medical) (2023)
Q1 Physiology (2023)
Kovács, F.,
Balla, N.,
Bozó, A.,
Harmath, A.,
Jakab, Á.,
Tóth, Z.,
Nagy, F.,
Majoros, L.,
Kovács, R.:
Epidemiology, clinical characteristics, outcome and biofilm forming properties in candidaemia: a single-centre retrospective 4-year analysis from Hungary.
Mycoses. 67 (4), 1-12, 2024.
Journal metrics:
Q1 Dermatology (2023)
Q2 Infectious Diseases (2023)
Q1 Medicine (miscellaneous) (2023)
2022
Spengler, G.,
Gajdács, M.,
Donadu, M.,
Usai, M.,
Marchetti, M.,
Ferrari, M.,
Mazzarello, V.,
Zanetti, S.,
Nagy, F.,
Kovács, R.:
Evaluation of the Antimicrobial and Antivirulent Potential of Essential Oils Isolated from Juniperus oxycedrus L. ssp. macrocarpa Aerial Parts.
Microorganisms. 10 (4), 1-20, 2022.
Journal metrics:
Q2 Microbiology
Q2 Microbiology (medical)
Q2 Virology
2021
Kovács, R.,
Tóth, Z.,
Locke, J.,
Forgács, L.,
Kardos, G.,
Nagy, F.,
Borman, A.,
Majoros, L.:
Comparison of In Vitro Killing Activity of Rezafungin, Anidulafungin, Caspofungin, and Micafungin against Four Candida auris Clades in RPMI-1640 in the Absence and Presence of Human Serum.
Microorganisms. 9 (4), 1-12, 2021.
Journal metrics:
Q2 Microbiology
Q2 Microbiology (medical)
Q3 Virology
Nagy, F.,
Tóth, Z.,
Váradi, G.,
Tóth, L.,
Forgács, L.,
Vadászi, K.,
Majoros, L.,
Galgóczy, L.,
Kovács, R.:
Echinocandinok és a Neosartorya fischeri antifungális fehérje 2 (NFAP2) kombinációjának in vitro vizsgálata Candida auris biofilmek ellen.
Acta Microbiol. Immunol. Hung. 68 28-29, 2021.
Nagy, F.,
Tóth, Z.,
Nyikos, F.,
Forgács, L.,
Jakab, Á.,
Borman, A.,
Majoros, L.,
Kovács, R.:
In vitro and in vivo interaction of caspofungin with isavuconazole against Candida auris planktonic cells and biofilms.
Med. Mycol. 59 (10), 1015-1023, 2021.
Journal metrics:
Q2 Infectious Diseases
Q2 Medicine (miscellaneous)
D1 Veterinary (miscellaneous)
Balázs, B.,
Nagy, J.,
Tóth, Z.,
Nagy, F.,
Károlyi, S.,
Turcsányi, I.,
Bistyák, A.,
Kálmán, A.,
Sárközi, R.,
Kardos, G.:
Occurrence of Escherichia coli producing extended spectrum [béta]-lactamases in food-producing animals.
Acta Vet. Hung. 69 (3), 1-5, 2021.
Journal metrics:
Q2 Veterinary (miscellaneous)
Jakab, Á.,
Emri, T.,
Csillag, K.,
Szabó, A.,
Nagy, F.,
Baranyai, E.,
Sajtos, Z.,
Géczi, D.,
Antal, K.,
Kovács, R.,
Szabó, K.,
Dombrádi, V.,
Pócsi, I.:
The negative effect of protein phosphatase Z1 deletion on the oxidative stress tolerance of Candida albicans is synergistic with betamethasone exposure.
J. Fungi. 7 (540), 1-24, 2021.
Journal metrics:
Q1 Ecology, Evolution, Behavior and Systematics
Q2 Microbiology (medical)
Q1 Plant Science
Kovács, R.,
Nagy, F.,
Tóth, Z.,
Forgács, L.,
Tóth, L.,
Váradi, G.,
Tóth, G.,
Vadászi, K.,
Borman, A.,
Majoros, L.,
Galgóczy, L.:
The Neosartorya fischeri Antifungal Protein 2 (NFAP2): a New Potential Weapon against Multidrug-Resistant Candida auris Biofilms.
Int. J. Mol. Sci. 22 (2), 1-14, 2021.
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
Q1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
Q1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
Balázs, B.,
Tóth, Z.,
Nagy, F.,
Kovács, R.,
Tóth, H.,
Nagy, J.,
Tóth, Á.,
Szarka, K.,
Majoros, L.,
Kardos, G.:
The Role of Uniform Meropenem Usage in Acinetobacter baumannii Clone Replacement.
Antibiotics. 10 (2), 1-12, 2021.
Journal metrics:
Q2 Biochemistry
Q2 Infectious Diseases
Q2 Microbiology
Q2 Microbiology (medical)
Q2 Pharmacology (medical)
Q1 Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Jakab, Á.,
Balla, N.,
Ragyák, Á.,
Nagy, F.,
Kovács, F.,
Sajtos, Z.,
Tóth, Z.,
Borman, A.,
Pócsi, I.,
Baranyai, E.,
Majoros, L.,
Kovács, R.:
Transcriptional profiling of the Candida auris response to exogenous farnesol exposure.
mSphere. 6 (5), 1-12, 2021.
Journal metrics:
Q1 Microbiology
Q2 Molecular Biology
Kovács, R.,
Jakab, Á.,
Ragyák, Á.,
Sajtos, Z.,
Nagy, F.,
Baranyai, E.,
Pócsi, I.,
Majoros, L.:
Transcriptomic approaches for the farnesol exposure of Candida auris.
Acta Microbiol. Immunol. Hung. 68 85, 2021.
2020
Vitális, E.,
Nagy, F.,
Tóth, Z.,
Forgács, L.,
Bozó, A.,
Kardos, G.,
Majoros, L.,
Kovács, R.:
Candida biofilm production is associated with higher mortality in patients with candidaemia.
Mycoses. 63 (4), 352-360, 2020.
Journal metrics:
Q1 Dermatology
Q2 Infectious Diseases
Q1 Medicine (miscellaneous)
Nemes, D.,
Kovács, R.,
Nagy, F.,
Tóth, Z.,
Herczegh, P.,
Borbás, A.,
Kelemen, V.,
Pfliegler, V.,
Rebenku, I.,
Hajdu, P.,
Fehér, P.,
Ujhelyi, Z.,
Fenyvesi, F.,
Váradi, J.,
Vecsernyés, M.,
Bácskay, I.:
Comparative biocompatibility and antimicrobial studies of sorbic acid derivates.
Eur. J. Pharm. Sci. 143 1-9, 2020.
Journal metrics:
Q1 Pharmaceutical Science
Forgács, L.,
Borman, A.,
Prépost, E.,
Tóth, Z.,
Kardos, G.,
Kovács, R.,
Székely, A.,
Nagy, F.,
Kovács, I.,
Majoros, L.:
Comparison of in vivo pathogenicity of four Candida auris clades in a neutropenic bloodstream infection murine model.
Emerg. Microbes Infect. 9 (1), 1160-1169, 2020.
Journal metrics:
D1 Drug Discovery
Q1 Epidemiology
Q1 Immunology
D1 Infectious Diseases
D1 Medicine (miscellaneous)
Q1 Microbiology
D1 Parasitology
Q1 Virology
Nagy, F.,
Vitális, E.,
Jakab, Á.,
Borman, A.,
Forgács, L.,
Tóth, Z.,
Majoros, L.,
Kovács, R.:
In vitro and in vivo effect of exogenous farnesol exposure against Candida auris.
Front. Microbiol. 11 1-12, 2020.
Journal metrics:
Q1 Microbiology
Q1 Microbiology (medical)
Tóth, Z.,
Forgács, L.,
Kardos, T.,
Kovács, R.,
Locke, J.,
Kardos, G.,
Nagy, F.,
Borman, A.,
Adnan, A.,
Majoros, L.:
Relative Frequency of Paradoxical Growth and Trailing Effect with Caspofungin, Micafungin, Anidulafungin, and the Novel Echinocandin Rezafungin against Candida Species.
J. Fungi. 6 (3), 1-9, 2020.
Journal metrics:
D1 Ecology, Evolution, Behavior and Systematics
Q1 Microbiology (medical)
D1 Plant Science
2019
Tóth, Z.,
Forgács, L.,
Locke, J.,
Kardos, G.,
Nagy, F.,
Kovács, R.,
Borman, A.,
Majoros, L.:
Comparison of killing activity of rezafungin, anidulafungin, caspofungin and micafungin against Candida auris in the presence and absence of serum.
J. Fungi. 5 (95), 130-131, 2019.
Prépost, E.,
Tóth, Z.,
Perlin, D.,
Gesztelyi, R.,
Kardos, G.,
Kovács, R.,
Nagy, F.,
Forgács, L.,
Majoros, L.:
Efficacy of humanized single large doses of caspofungin on the lethality and fungal tissue burden in a deeply neutropenic murine model against Candida albicans and Candida dubliniensis.
Infect Drug Resist. 12 1805-1814, 2019.
Journal metrics:
Q2 Infectious Diseases
Q1 Pharmacology
Q2 Pharmacology (medical)
Nagy, F.,
Tóth, Z.,
Daróczi, L.,
Székely, A.,
Borman, A.,
Majoros, L.,
Kovács, R.:
Farnesol increases the activity of echinocandins against Candida auris biofilms.
Med. Mycol. 58 (3), 404-407, 2019.
Journal metrics:
Q2 Infectious Diseases
Q1 Medicine (miscellaneous)
D1 Veterinary (miscellaneous)
Nagy, F.,
Tóth, Z.,
Bozó, A.,
Czeglédi, A.,
Rebenku, I.,
Majoros, L.,
Kovács, R.:
Fluconazole is not inferior than caspofungin, micafungin or amphotericin B in the presence of 50% human serum against Candida albicans and Candida parapsilosis biofilms.
Med. Mycol. 57 (5), 573-581, 2019.
Journal metrics:
Q2 Infectious Diseases
Q1 Medicine (miscellaneous)
D1 Veterinary (miscellaneous)
Forgács, L.,
Tóth, Z.,
Locke, J.,
Nagy, F.,
Balázs, B.,
Prépost, E.,
Kardos, G.,
Kovács, R.,
Székely, A.,
Borman, A.,
Majoros, L.:
Frequency of paradoxical and trailing effects with rezafungin, anidulafungin, caspofungin and micafungin against Candida species.
J. Fungi. 5 (95), 131-132, 2019.
Tóth, Z.,
Forgács, L.,
Locke, J.,
Kardos, G.,
Nagy, F.,
Kovács, R.,
Székely, A.,
Borman, A.,
Majoros, L.:
In vitro activity of rezafungin against common and rare Candida species and Saccharomyces cerevisiae.
J. Antimicrob. Chemother. 74 (12), 3505-3510, 2019.
Journal metrics:
D1 Infectious Diseases
D1 Microbiology (medical)
D1 Pharmacology
D1 Pharmacology (medical)
Jakab, Á.,
Tóth, Z.,
Nagy, F.,
Nemes, D.,
Bácskay, I.,
Kardos, G.,
Emri, T.,
Pócsi, I.,
Majoros, L.,
Kovács, R.:
Physiological and transcriptional response of Candida parapsilosis to exogenous tyrosol.
Appl. Environ. Microbiol. 85 (20), 1-12, 2019.
Journal metrics:
D1 Applied Microbiology and Biotechnology
Q1 Biotechnology
D1 Ecology
D1 Food Science
Kovács, R.,
Nagy, F.,
Tóth, Z.,
Bozó, A.,
Balázs, B.,
Majoros, L.:
Synergistic effect of nikkomycin Z with caspofungin and micafungin against Candida albicans and Candida parapsilosis biofilms.
Lett. Appl. Microbiol. 69 (4), 271-278, 2019.
Journal metrics:
Q2 Applied Microbiology and Biotechnology
2024
Jakab, Á.,
Kovács, F.,
Balla, N.,
Nagy-Köteles, C.,
Ragyák, Á.,
Nagy, F.,
Borman, A.,
Majoros, L.,
Kovács, R.:
Comparative transcriptional analysis of Candida auris biofilms following farnesol and tyrosol treatment.
Microbiol. Spectr. 12 (4), 1-12, 2024.
Journal metrics:
Q2 Cell Biology (2023)
Q1 Ecology (2023)
Q2 Genetics (2023)
Q1 Immunology and Microbiology (miscellaneous) (2023)
Q1 Infectious Diseases (2023)
Q2 Microbiology (medical) (2023)
Q1 Physiology (2023)
Kovács, F.,
Balla, N.,
Bozó, A.,
Harmath, A.,
Jakab, Á.,
Tóth, Z.,
Nagy, F.,
Majoros, L.,
Kovács, R.:
Epidemiology, clinical characteristics, outcome and biofilm forming properties in candidaemia: a single-centre retrospective 4-year analysis from Hungary.
Mycoses. 67 (4), 1-12, 2024.
Journal metrics:
Q1 Dermatology (2023)
Q2 Infectious Diseases (2023)
Q1 Medicine (miscellaneous) (2023)
2022
Spengler, G.,
Gajdács, M.,
Donadu, M.,
Usai, M.,
Marchetti, M.,
Ferrari, M.,
Mazzarello, V.,
Zanetti, S.,
Nagy, F.,
Kovács, R.:
Evaluation of the Antimicrobial and Antivirulent Potential of Essential Oils Isolated from Juniperus oxycedrus L. ssp. macrocarpa Aerial Parts.
Microorganisms. 10 (4), 1-20, 2022.
Journal metrics:
Q2 Microbiology
Q2 Microbiology (medical)
Q2 Virology
2021
Kovács, R.,
Tóth, Z.,
Locke, J.,
Forgács, L.,
Kardos, G.,
Nagy, F.,
Borman, A.,
Majoros, L.:
Comparison of In Vitro Killing Activity of Rezafungin, Anidulafungin, Caspofungin, and Micafungin against Four Candida auris Clades in RPMI-1640 in the Absence and Presence of Human Serum.
Microorganisms. 9 (4), 1-12, 2021.
Journal metrics:
Q2 Microbiology
Q2 Microbiology (medical)
Q3 Virology
Nagy, F.,
Tóth, Z.,
Váradi, G.,
Tóth, L.,
Forgács, L.,
Vadászi, K.,
Majoros, L.,
Galgóczy, L.,
Kovács, R.:
Echinocandinok és a Neosartorya fischeri antifungális fehérje 2 (NFAP2) kombinációjának in vitro vizsgálata Candida auris biofilmek ellen.
Acta Microbiol. Immunol. Hung. 68 28-29, 2021.
Nagy, F.,
Tóth, Z.,
Nyikos, F.,
Forgács, L.,
Jakab, Á.,
Borman, A.,
Majoros, L.,
Kovács, R.:
In vitro and in vivo interaction of caspofungin with isavuconazole against Candida auris planktonic cells and biofilms.
Med. Mycol. 59 (10), 1015-1023, 2021.
Journal metrics:
Q2 Infectious Diseases
Q2 Medicine (miscellaneous)
D1 Veterinary (miscellaneous)
Balázs, B.,
Nagy, J.,
Tóth, Z.,
Nagy, F.,
Károlyi, S.,
Turcsányi, I.,
Bistyák, A.,
Kálmán, A.,
Sárközi, R.,
Kardos, G.:
Occurrence of Escherichia coli producing extended spectrum [béta]-lactamases in food-producing animals.
Acta Vet. Hung. 69 (3), 1-5, 2021.
Journal metrics:
Q2 Veterinary (miscellaneous)
Jakab, Á.,
Emri, T.,
Csillag, K.,
Szabó, A.,
Nagy, F.,
Baranyai, E.,
Sajtos, Z.,
Géczi, D.,
Antal, K.,
Kovács, R.,
Szabó, K.,
Dombrádi, V.,
Pócsi, I.:
The negative effect of protein phosphatase Z1 deletion on the oxidative stress tolerance of Candida albicans is synergistic with betamethasone exposure.
J. Fungi. 7 (540), 1-24, 2021.
Journal metrics:
Q1 Ecology, Evolution, Behavior and Systematics
Q2 Microbiology (medical)
Q1 Plant Science
Kovács, R.,
Nagy, F.,
Tóth, Z.,
Forgács, L.,
Tóth, L.,
Váradi, G.,
Tóth, G.,
Vadászi, K.,
Borman, A.,
Majoros, L.,
Galgóczy, L.:
The Neosartorya fischeri Antifungal Protein 2 (NFAP2): a New Potential Weapon against Multidrug-Resistant Candida auris Biofilms.
Int. J. Mol. Sci. 22 (2), 1-14, 2021.
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
Q1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
Q1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
Balázs, B.,
Tóth, Z.,
Nagy, F.,
Kovács, R.,
Tóth, H.,
Nagy, J.,
Tóth, Á.,
Szarka, K.,
Majoros, L.,
Kardos, G.:
The Role of Uniform Meropenem Usage in Acinetobacter baumannii Clone Replacement.
Antibiotics. 10 (2), 1-12, 2021.
Journal metrics:
Q2 Biochemistry
Q2 Infectious Diseases
Q2 Microbiology
Q2 Microbiology (medical)
Q2 Pharmacology (medical)
Q1 Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Jakab, Á.,
Balla, N.,
Ragyák, Á.,
Nagy, F.,
Kovács, F.,
Sajtos, Z.,
Tóth, Z.,
Borman, A.,
Pócsi, I.,
Baranyai, E.,
Majoros, L.,
Kovács, R.:
Transcriptional profiling of the Candida auris response to exogenous farnesol exposure.
mSphere. 6 (5), 1-12, 2021.
Journal metrics:
Q1 Microbiology
Q2 Molecular Biology
Kovács, R.,
Jakab, Á.,
Ragyák, Á.,
Sajtos, Z.,
Nagy, F.,
Baranyai, E.,
Pócsi, I.,
Majoros, L.:
Transcriptomic approaches for the farnesol exposure of Candida auris.
Acta Microbiol. Immunol. Hung. 68 85, 2021.
2020
Vitális, E.,
Nagy, F.,
Tóth, Z.,
Forgács, L.,
Bozó, A.,
Kardos, G.,
Majoros, L.,
Kovács, R.:
Candida biofilm production is associated with higher mortality in patients with candidaemia.
Mycoses. 63 (4), 352-360, 2020.
Journal metrics:
Q1 Dermatology
Q2 Infectious Diseases
Q1 Medicine (miscellaneous)
Nemes, D.,
Kovács, R.,
Nagy, F.,
Tóth, Z.,
Herczegh, P.,
Borbás, A.,
Kelemen, V.,
Pfliegler, V.,
Rebenku, I.,
Hajdu, P.,
Fehér, P.,
Ujhelyi, Z.,
Fenyvesi, F.,
Váradi, J.,
Vecsernyés, M.,
Bácskay, I.:
Comparative biocompatibility and antimicrobial studies of sorbic acid derivates.
Eur. J. Pharm. Sci. 143 1-9, 2020.
Journal metrics:
Q1 Pharmaceutical Science
Forgács, L.,
Borman, A.,
Prépost, E.,
Tóth, Z.,
Kardos, G.,
Kovács, R.,
Székely, A.,
Nagy, F.,
Kovács, I.,
Majoros, L.:
Comparison of in vivo pathogenicity of four Candida auris clades in a neutropenic bloodstream infection murine model.
Emerg. Microbes Infect. 9 (1), 1160-1169, 2020.
Journal metrics:
D1 Drug Discovery
Q1 Epidemiology
Q1 Immunology
D1 Infectious Diseases
D1 Medicine (miscellaneous)
Q1 Microbiology
D1 Parasitology
Q1 Virology
Nagy, F.,
Vitális, E.,
Jakab, Á.,
Borman, A.,
Forgács, L.,
Tóth, Z.,
Majoros, L.,
Kovács, R.:
In vitro and in vivo effect of exogenous farnesol exposure against Candida auris.
Front. Microbiol. 11 1-12, 2020.
Journal metrics:
Q1 Microbiology
Q1 Microbiology (medical)
Tóth, Z.,
Forgács, L.,
Kardos, T.,
Kovács, R.,
Locke, J.,
Kardos, G.,
Nagy, F.,
Borman, A.,
Adnan, A.,
Majoros, L.:
Relative Frequency of Paradoxical Growth and Trailing Effect with Caspofungin, Micafungin, Anidulafungin, and the Novel Echinocandin Rezafungin against Candida Species.
J. Fungi. 6 (3), 1-9, 2020.
Journal metrics:
D1 Ecology, Evolution, Behavior and Systematics
Q1 Microbiology (medical)
D1 Plant Science
2019
Tóth, Z.,
Forgács, L.,
Locke, J.,
Kardos, G.,
Nagy, F.,
Kovács, R.,
Borman, A.,
Majoros, L.:
Comparison of killing activity of rezafungin, anidulafungin, caspofungin and micafungin against Candida auris in the presence and absence of serum.
J. Fungi. 5 (95), 130-131, 2019.
Prépost, E.,
Tóth, Z.,
Perlin, D.,
Gesztelyi, R.,
Kardos, G.,
Kovács, R.,
Nagy, F.,
Forgács, L.,
Majoros, L.:
Efficacy of humanized single large doses of caspofungin on the lethality and fungal tissue burden in a deeply neutropenic murine model against Candida albicans and Candida dubliniensis.
Infect Drug Resist. 12 1805-1814, 2019.
Journal metrics:
Q2 Infectious Diseases
Q1 Pharmacology
Q2 Pharmacology (medical)
Nagy, F.,
Tóth, Z.,
Daróczi, L.,
Székely, A.,
Borman, A.,
Majoros, L.,
Kovács, R.:
Farnesol increases the activity of echinocandins against Candida auris biofilms.
Med. Mycol. 58 (3), 404-407, 2019.
Journal metrics:
Q2 Infectious Diseases
Q1 Medicine (miscellaneous)
D1 Veterinary (miscellaneous)
Nagy, F.,
Tóth, Z.,
Bozó, A.,
Czeglédi, A.,
Rebenku, I.,
Majoros, L.,
Kovács, R.:
Fluconazole is not inferior than caspofungin, micafungin or amphotericin B in the presence of 50% human serum against Candida albicans and Candida parapsilosis biofilms.
Med. Mycol. 57 (5), 573-581, 2019.
Journal metrics:
Q2 Infectious Diseases
Q1 Medicine (miscellaneous)
D1 Veterinary (miscellaneous)
Forgács, L.,
Tóth, Z.,
Locke, J.,
Nagy, F.,
Balázs, B.,
Prépost, E.,
Kardos, G.,
Kovács, R.,
Székely, A.,
Borman, A.,
Majoros, L.:
Frequency of paradoxical and trailing effects with rezafungin, anidulafungin, caspofungin and micafungin against Candida species.
J. Fungi. 5 (95), 131-132, 2019.
Tóth, Z.,
Forgács, L.,
Locke, J.,
Kardos, G.,
Nagy, F.,
Kovács, R.,
Székely, A.,
Borman, A.,
Majoros, L.:
In vitro activity of rezafungin against common and rare Candida species and Saccharomyces cerevisiae.
J. Antimicrob. Chemother. 74 (12), 3505-3510, 2019.
Journal metrics:
D1 Infectious Diseases
D1 Microbiology (medical)
D1 Pharmacology
D1 Pharmacology (medical)
Jakab, Á.,
Tóth, Z.,
Nagy, F.,
Nemes, D.,
Bácskay, I.,
Kardos, G.,
Emri, T.,
Pócsi, I.,
Majoros, L.,
Kovács, R.:
Physiological and transcriptional response of Candida parapsilosis to exogenous tyrosol.
Appl. Environ. Microbiol. 85 (20), 1-12, 2019.
Journal metrics:
D1 Applied Microbiology and Biotechnology
Q1 Biotechnology
D1 Ecology
D1 Food Science
Kovács, R.,
Nagy, F.,
Tóth, Z.,
Bozó, A.,
Balázs, B.,
Majoros, L.:
Synergistic effect of nikkomycin Z with caspofungin and micafungin against Candida albicans and Candida parapsilosis biofilms.
Lett. Appl. Microbiol. 69 (4), 271-278, 2019.
Journal metrics:
Q2 Applied Microbiology and Biotechnology
Nagy, F.,
Tóth, Z.,
Forgács, L.,
Borman, A.,
Majoros, L.,
Balázs, B.,
Kovács, R.:
The effect of farnesol on Candida auris biofilms, virulence and azole susceptibility.
J. Fungi. 95 (5), 141-142, 2019.
Kovács, R.,
Jakab, Á.,
Tóth, Z.,
Nagy, F.,
Emri, T.,
Pócsi, I.,
Majoros, L.:
Transcriptional and physiological effect exerted by tyrosol on Candida parapsilosis cells.
J. Fungi. 5 (95), 142-143, 2019.
2018
Tóth, Z.,
Kardos, T.,
Kovács, R.,
Kardos, G.,
Nagy, F.,
Prépost, E.,
Barta, Z.,
Takács, I.,
Majoros, L.:
Comparison of Killing Activity of Micafungin Against Six Candida Species Isolated from Peritoneal and Pleural Cavities in RPMI-1640, 10 and 30% Serum.
Mycopathologia. 183 (6), 905-912, 2018.
Journal metrics:
Q2 Agronomy and Crop Science
Q2 Applied Microbiology and Biotechnology
Q3 Microbiology
Q2 Plant Science
Q1 Veterinary (miscellaneous)
Nemes, D.,
Kovács, R.,
Nagy, F.,
Mező, M.,
Poczok, N.,
Ujhelyi, Z.,
Pető, Á.,
Fehér, P.,
Fenyvesi, F.,
Váradi, J.,
Vecsernyés, M.,
Bácskay, I.:
Interaction between Different Pharmaceutical Excipients in Liquid Dosage Forms: assessment of Cytotoxicity and Antimicrobial Activity.
Molecules. 23 (7), 1-19, 2018.
Journal metrics:
Q2 Analytical Chemistry
Q1 Chemistry (miscellaneous)
Q2 Drug Discovery
Q2 Medicine (miscellaneous)
Q3 Molecular Medicine
Q2 Organic Chemistry
Q1 Pharmaceutical Science
Q2 Physical and Theoretical Chemistry
Nagy, F.,
Bozó, A.,
Tóth, Z.,
Daróczi, L.,
Majoros, L.,
Kovács, R.:
In vitro antifungal susceptibility patterns of planktonic and sessile Candida kefyr clinical isolates.
Med. Mycol. 56 (4), 493-500, 2018.
Journal metrics:
Q2 Infectious Diseases
Q1 Medicine (miscellaneous)
D1 Veterinary (miscellaneous)
Kardos, T.,
Kovács, R.,
Kardos, G.,
Varga, I.,
Bozó, A.,
Tóth, Z.,
Nagy, F.,
Majoros, L.:
Poor in vivo efficacy of caspofungin, micafungin and amphotericin B against wild-type Candida krusei clinical isolates does not correlate with in vitro susceptibility results.
J. Chemother. 30 (4), 233-239, 2018.
Journal metrics:
Q3 Infectious Diseases
Q2 Medicine (miscellaneous)
Q3 Oncology
Q3 Pharmacology
Q3 Pharmacology (medical)
Kovács, R.,
Nagy, F.,
Tóth, Z.,
Bozó, A.,
Majoros, L.:
The effect of human serum on the efficacy of traditional antifungals against Candida albicans and Candida parapsilosis biofilms.
Med. Mycol. 56 S131, 2018.
Jakab, Á.,
Nagy, F.,
Tóth, Z.,
Nemes, D.,
Majoros, L.,
Bácskay, I.,
Pócsi, I.,
Kovács, R.:
Tyrosol influences the physiology and virulence of Candida parapsilosis.
In: Fiatal Biotechnológusok Országos Konferenciája. Szerk.: Tamás László, Zelenyánszki Helga, JATEPress, Szeged, 95, 2018. ISBN: 9789633153703
2017
Kovács, R.,
Tóth, Z.,
Nagy, F.,
Daróczi, L.,
Bozó, A.,
Majoros, L.:
Activity of exogenous tyrosol in combination with caspofungin and micafungin against Candida parapsilosis sessile cells.
J. Appl. Microbiol. 122 (6), 1529-1536, 2017.
Journal metrics:
Q2 Applied Microbiology and Biotechnology
Q2 Biotechnology
Q2 Medicine (miscellaneous)
Kovács, R.,
Nagy, F.,
Bozó, A.,
Tóth, Z.,
Daróczi, L.,
Kardos, G.,
Majoros, L.:
The in vitro susceptibility pattern of C. kefyr planktonic cells and biofilms against traditional antifungal agents.
Acta Microbiol. Immunol. Hung. 62 152, 2017.
2016
Kovács, R.,
Bozó, A.,
Gesztelyi, R.,
Domán, M.,
Kardos, G.,
Nagy, F.,
Tóth, Z.,
Majoros, L.:
Effect of caspofungin and micafungin in combination with farnesol against Candida parapsilosis biofilms.
Int. J. Antimicrob. Agents. 47 (4), 304-310, 2016.
Journal metrics:
Q1 Infectious Diseases
D1 Medicine (miscellaneous)
Q1 Microbiology (medical)
D1 Pharmacology (medical)
Kovács, R.,
Bozó, A.,
Nagy, F.,
Tóth, Z.,
Majoros, L.:
The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model.
Acta Microbiol. Immunol. Hung. 64 16, 2016.
2015
Kovács, R.,
Bozó, A.,
Domán, M.,
Nagy, F.,
Tóth, Z.,
Majoros, L.:
Effect of caspofungin and micafungin in combination with farnesol against Candida parapsilosis biofilms.
Mycoses. 58 79-80, 2015.
Show all
updated: 2024-11-10, 02:14